Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Follow on https://twitter.com/peterrost
Friday, April 30, 2010
Thursday, April 29, 2010
Wednesday, April 28, 2010
Tuesday, April 27, 2010
How to turn a young boy into a killing machine in 10 weeks. (Video)
In 1983, the National Film Board of Canada produced a 57-minute film, "Anybody's Son Will Do".
The film shows the process by which young men become psychologically engineered to kill or die on command. While the model used is the U.S. Marine Corps, it's made clear that the modern techniques for creating soldiers are refined, dehumanizing and universal.
The film shows the process by which young men become psychologically engineered to kill or die on command. While the model used is the U.S. Marine Corps, it's made clear that the modern techniques for creating soldiers are refined, dehumanizing and universal.
Part I
Part II
Part III
Part IV
Part V
Part VI
Monday, April 26, 2010
Sunday, April 25, 2010
Saturday, April 24, 2010
Friday, April 23, 2010
The most popular T-shirt in the history of shopping!
Check out the 1,724 reviews on Amazon. Really, please do.
Thursday, April 22, 2010
How much has PFE shareholders lost since Jeff Kindler became CEO?
This much.
And, today Pfizer shareholders rejected ban on stock options. Guess they're hoping for better times.
And, today Pfizer shareholders rejected ban on stock options. Guess they're hoping for better times.
What do women really think, and like?
Find out in Esquire's survey!
Wednesday, April 21, 2010
Tuesday, April 20, 2010
Monday, April 19, 2010
I think she is doing a public health service - but not everyone agrees.
U of M President Accused of Ethical Conflict
By Tom Gantert
April 17, 2010
Michigan Capitol Confidential
In 2009, the University of Michigan announced that its three campuses - Ann Arbor, Flint and Dearborn - would be smoke-free on July 1, 2011.
The University of Michigan's student newspaper - The Michigan Daily - wrote an opinion piece last week suggesting a conflict of interest involving University of Michigan President Mary Sue Coleman.
Coleman also earned a $230,000 salary in 2009 for sitting on the board of Johnson & Johnson. Alza Corporation, a subsidiary of Johnson & Johnson, markets Nicorette and Nicoderm, smoking cessation products.
Three ethics experts say Coleman is not in conflict.
"She is doing a public health service," Peter Rost, a former vice president of Pfizer who has testified before Congress on the business practices of drug companies, wrote in an e-mail. "The possible income by J&J from this campus is completely and utterly negligible and will have no impact on J&J income statement. Same thing if she opened public health clinic for depressed students and happened to sit on board of (a company) selling antidepressants. Conflict of interest should normally have some undue influence on either party. Since that is not the case I'm not troubled."
Aine Donovan, the executive director of the Ethics Institute at Dartmouth College who teaches business ethics, said she didn't see a conflict.
"This is very reasonable," Donovan said. "Johnson & Johnson has a large range of products. This is a very reasonable position she is taking and it is a very laudable one."
Timothy Keane, director of the Emerson Ethics Center in St. Louis, said it was "a bit of a stretch" to say Coleman had a conflict of interest.
"Johnson & Johnson is not trying to set up shop and sell something to the University," Keane said. "They are not being a supplier to the University. It doesn't matter if you are a smoker or not, research indicates it is bad for you."
Michigan Capitol Confidential
By Tom Gantert
April 17, 2010
Michigan Capitol Confidential
In 2009, the University of Michigan announced that its three campuses - Ann Arbor, Flint and Dearborn - would be smoke-free on July 1, 2011.
The University of Michigan's student newspaper - The Michigan Daily - wrote an opinion piece last week suggesting a conflict of interest involving University of Michigan President Mary Sue Coleman.
Coleman also earned a $230,000 salary in 2009 for sitting on the board of Johnson & Johnson. Alza Corporation, a subsidiary of Johnson & Johnson, markets Nicorette and Nicoderm, smoking cessation products.
Three ethics experts say Coleman is not in conflict.
"She is doing a public health service," Peter Rost, a former vice president of Pfizer who has testified before Congress on the business practices of drug companies, wrote in an e-mail. "The possible income by J&J from this campus is completely and utterly negligible and will have no impact on J&J income statement. Same thing if she opened public health clinic for depressed students and happened to sit on board of (a company) selling antidepressants. Conflict of interest should normally have some undue influence on either party. Since that is not the case I'm not troubled."
Aine Donovan, the executive director of the Ethics Institute at Dartmouth College who teaches business ethics, said she didn't see a conflict.
"This is very reasonable," Donovan said. "Johnson & Johnson has a large range of products. This is a very reasonable position she is taking and it is a very laudable one."
Timothy Keane, director of the Emerson Ethics Center in St. Louis, said it was "a bit of a stretch" to say Coleman had a conflict of interest.
"Johnson & Johnson is not trying to set up shop and sell something to the University," Keane said. "They are not being a supplier to the University. It doesn't matter if you are a smoker or not, research indicates it is bad for you."
Michigan Capitol Confidential
Sunday, April 18, 2010
Saturday, April 17, 2010
Friday, April 16, 2010
Wednesday, April 14, 2010
Tuesday, April 13, 2010
Thursday, April 01, 2010
Subscribe to:
Posts (Atom)